We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+6.64%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$1.51B
AUM Growth
+$87.6M
(+6.2%)
Cap. Flow
+$5.84M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
24.85%
Holding
285
New
22
Increased
90
Reduced
119
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$9.3M |
| 2 |
PayPal
PYPL
|
+$8.3M |
| 3 |
Diamondback Energy
FANG
|
+$6.29M |
| 4 |
Ecolab
ECL
|
+$6.27M |
| 5 |
Cisco
CSCO
|
+$6.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$17.6M |
| 2 |
CVS Health
CVS
|
+$10.4M |
| 3 |
American International
AIG
|
+$6.23M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.5M |
| 5 |
Cognizant
CTSH
|
+$5.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.81% |
| 2 | Technology | 14.48% |
| 3 | Healthcare | 13.69% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Discretionary | 9.75% |
Similar funds
ZCM
CQS
WSTAM
CW
SCM
AFIMH
ICG
DA
Cambridge Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Cambridge Trust held 285 positions worth $1.51B, up 6.2% from $1.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Cambridge Trust's Q1 2017 filing shows 22 new, 90 increased, 119 reduced and 16 closed positions. Its largest new stake was PayPal: 198,424 shares worth $8.54M. The largest sale was ExxonMobil, an estimated $17.6M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.
- Cambridge Trust's largest Q1 2017 buy was PayPal: 198,424 shares worth $8.54M.
- Cambridge Trust added most to iShares MSCI Emerging Markets ETF in Q1 2017, an estimated $9.3M increase.
- Cambridge Trust's biggest Q1 2017 reduction was ExxonMobil, cutting an estimated $17.6M.
- Cambridge Trust fully exited Edwards Lifesciences in Q1 2017, selling an estimated $1.87M.
- Cambridge Trust's ten largest holdings make up 25% of its $1.51B portfolio in Q1 2017.
- Cambridge Trust opened 22 new positions and closed 16 in Q1 2017.
- Cambridge Trust's portfolio value rose 6.2% quarter-over-quarter to $1.51B.
Based on Cambridge Trust's 13F filing for Q1 2017, filed 19 May 2017.